Article
Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production.
Experimental hematology - 1 Feb 1999
Jelkmann W, Hellwig-Buergel T
Abstract excerpt
Tumor necrosis factor alpha (TNFalpha) is thought to contribute to the blunted erythropoietin (Epo) production in inflammatory diseases. The present study was carried out to find out as to whether the 55 kD (TNF-RI) or the 75 kD (TNF-RII) receptor is responsible for the TNFalpha-induced inhibition of hepatic Epo synthesis. When the effects of two receptor-specific mutants were compared, only the TNF-RI-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
